Advertisement | | RNA-Seq just went from complicated to compatible. Expression Analysis will provide your data in a format you are used to -- 100% microarray compatible format. Now you can have your data and use it too! EA will help you detect 2x more differentially expressed transcripts, novel isoforms and SNVs and can achieve >97% alignment. 919-405-2248 * 866-293-6094 | | | | |
TABLE OF CONTENTS | February 2013 Volume 31, Issue 2 | | | | | Editorial News Bioentrepreneur Opinion and Comment Features News and Views Computational Biology Research Careers and Recruitment
| | | | | | Advertisement | | | | | Advertisement | | Nature Biotechnology Focus on DNA Sequencing Technology Performance gains and falling costs have fueled diverse applications of high-throughput DNA sequencing. This focus issue summarizes the current status of these technologies as applied to life sciences and medical research. Click here to access the Focus! Produced with support from: | | | | Editorial | Top | | | | Dishing out cancer treatment p85 doi:10.1038/nbt.2516 Despite their limitations, in vitro assays are a simple means for assessing the drug sensitivity of a patient's cancer. After consulting experts in the community, we think such assays deserve a second look.
| | News | Top | | | | Amgen punts on deCODE's genetics know-how pp87 - 88 Cormac Sheridan doi:10.1038/nbt0213-87
| | | | Chinese investors tap US biotechs p88 Hepeng Jia doi:10.1038/nbt0213-88
| | | | First novel anti-tuberculosis drug in 40 years pp89 - 91 Randy Osborne doi:10.1038/nbt0213-89
| | | | Citizen microbiome p90 Moheb Costandi doi:10.1038/nbt0213-90a
| | | | Gilead widens cancer focus p90 Malorye Allison doi:10.1038/nbt0213-90b
| | | | Isis inks two antisense deals p91 Malorye Allison doi:10.1038/nbt0213-91a
| | | | Forty fight rust and rot p91 Lucas Laursen doi:10.1038/nbt0213-91b
| | | | Exelixis debuts in rare cancer p92 Malini Guha doi:10.1038/nbt0213-92a
| | | | First drug for short-bowel p92 Emma Dorey doi:10.1038/nbt0213-92b
| | | | Startups, inventors cheer European unified patent pp92 - 93 Nuala Moran doi:10.1038/nbt0213-92c
| | | | Egg-free flu vaccines p93 Jeffrey L Fox doi:10.1038/nbt0213-93a
| | | | UK science's Christmas gift p93 Barbara Casassus doi:10.1038/nbt0213-93b
| | | | BioTime acquires Geron's stem cell program p94 Vicki Brower doi:10.1038/nbt0213-94a
| | | | Brustle patent holds up in Germany p94 Nuala Moran doi:10.1038/nbt0213-94b
| | | | Industry backs biocatalysis for greener manufacturing pp95 - 96 Susan Aldridge doi:10.1038/nbt0213-95
| | | | All conflicts of interest in one site p97 Jeffrey L Fox doi:10.1038/nbt0213-97a
| | | | Around the world in a month p97 doi:10.1038/nbt0213-97b
| | | | Editor's Pick | | | | Inovio p98 Jennifer Rohn doi:10.1038/nbt0213-98 A Pennsylvania company hopes to turn synthetic DNA vaccines into rapid response agents against flu epidemics and cancer.
| | | | Data Page | | | | 2012—Bullish for big biotech p99 Walter Yang doi:10.1038/nbt.2504
| | | | News Feature | | | | Fresh from the biotech pipeline—2012 pp100 - 103 Randy Osborne doi:10.1038/nbt.2498 FDA approvals hit a new high mark in 2012, with a December flurry of approvals. Orphan and fast-track drugs showed strong in the list. Randy Osborne reports.
| | Bioentrepreneur | Top | | | | Building a business | | | | Giving voice to India's entrepreneurs pp104 - 107 Gayatri Saberwal doi:10.1038/nbt.2493
| | Opinion and Comment | Top | | | | Correspondence | | | | Prize-based contests can provide solutions to computational biology problems pp108 - 111 Karim R Lakhani, Kevin J Boudreau, Po-Ru Loh, Lars Backstrom, Carliss Baldwin, Eric Lonstein, Mike Lydon, Alan MacCormack, Ramy A Arnaout and Eva C Guinan doi:10.1038/nbt.2495
| | | | Commercialized transgenic traits, maize productivity and yield risk pp111 - 114 Guanming Shi, Jean-Paul Chavas and Joseph Lauer doi:10.1038/nbt.2496
| | | | Commentary | | | | Liquid refreshment p115 Christopher Scott doi:10.1038/nbt.2481 Compared with the long time horizons and diminished returns of traditional antibody startups, Ablexis gave investors a deal they couldn't refuse.
| | Features | Top | | | | Patents | | | | Intellectual property rights and user facility agreements pp116 - 117 Francis Hane doi:10.1038/nbt.2494 Scientific collaborations can produce results greater than the sum of their parts, but determining who owns the IP rights to scientific results is of prime importance.
| | | | Recent patent applications in polyethylene glycosylation p118 doi:10.1038/nbt.2513
| | News and Views | Top | | | | | | Computational Biology | Top | | | | Analysis | | | | Evaluation of methods for modeling transcription factor sequence specificity pp126 - 134 Matthew T Weirauch, Atina Cote, Raquel Norel, Matti Annala, Yue Zhao, Todd R Riley, Julio Saez-Rodriguez, Thomas Cokelaer, Anastasia Vedenko, Shaheynoor Talukder, Phaedra Agius, Aaron Arvey, Philipp Bucher, Curtis G Callan Jr, Cheng Wei Chang, Chien-Yu Chen, Yong-Syuan Chen, Yu-Wei Chu, Jan Grau, Ivo Grosse, Vidhya Jagannathan, Jens Keilwagen, Szymon M Kielbasa, Justin B Kinney, Holger Klein, Miron B Kursa, Harri Lahdesmaki, Kirsti Laurila, Chengwei Lei, Christina Leslie, Chaim Linhart, Anand Murugan, Alena Mysickova, William Stafford Noble, Matti Nykter, Yaron Orenstein, Stefan Posch, Jianhua Ruan, Witold R Rudnicki, Christoph D Schmid, Ron Shamir, Wing-Kin Sung, Martin Vingron, Zhizhuo Zhang, DREAM5 Consortium: Phaedra Agius, Aaron Arvey, Philipp Bucher, Curtis G Callan Jr, Cheng Wei Chang, Chien-Yu Chen, Yong-Syuan Chen, Yu-Wei Chu, Jan Grau, Ivo Grosse, Vidhya Jagannathan, Jens Keilwagen, Szymon M Kielbasa, Justin B Kinney, Holger Klein, Miron B Kursa, Harri Lahdesmaki, Kirsti Laurila, Chengwei Lei, Christina Leslie, Chaim Linhart, Anand Murugan, Alena Mysickova, William Stafford Noble, Matti Nykter, Yaron Orenstein, Stefan Posch, Jianhua Ruan, Witold R Rudnicki, Christoph D Schmid, Ron Shamir, Wing-Kin Sung, Martin Vingron and Zhizhuo Zhang Harmen J Bussemaker, Quaid D Morris, Martha L Bulyk, Gustavo Stolovitzky and Timothy R Hughes doi:10.1038/nbt.2486 The most comprehensive analysis to date of models of transcription-factor binding specificity reveals the best methods for predicting in vivo binding from in vitro data.
| | Research | Top | | | | Articles | | | | Sequencing and automated whole-genome optical mapping of the genome of a domestic goat (Capra hircus) OPEN pp135 - 141 Yang Dong, Min Xie, Yu Jiang, Nianqing Xiao, Xiaoyong Du, Wenguang Zhang, Gwenola Tosser-Klopp, Jinhuan Wang, Shuang Yang, Jie Liang, Wenbin Chen, Jing Chen, Peng Zeng, Yong Hou, Chao Bian, Shengkai Pan, Yuxiang Li, Xin Liu, Wenliang Wang, Bertrand Servin, Brian Sayre, Bin Zhu, Deacon Sweeney, Rich Moore, Wenhui Nie, Yongyi Shen, Ruoping Zhao, Guojie Zhang, Jinquan Li, Thomas Faraut, James Womack, Yaping Zhang, James Kijas, Noelle Cockett, Xun Xu, Shuhong Zhao, Jun Wang and Wen Wang doi:10.1038/nbt.2478 An instrument for whole-genome optical mapping is used to assemble the genome of the domestic goat into super-long scaffolds.
See also: News and Views by Mak
| | | | Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis pp142 - 147 Yun Liu, Martin J Aryee, Leonid Padyukov, M Daniele Fallin, Espen Hesselberg, Arni Runarsson, Lovisa Reinius, Nathalie Acevedo, Margaret Taub, Marcus Ronninger, Klementy Shchetynsky, Annika Scheynius, Juha Kere, Lars Alfredsson, Lars Klareskog, Tomas J Ekstrom and Andrew P Feinberg doi:10.1038/nbt.2487 Liu et al. use mediation analysis to find changes in DNA methylation that mediate the genetic risk for rheumatoid arthritis.
| | | | Targeted zwitterionic near-infrared fluorophores for improved optical imaging pp148 - 153 Hak Soo Choi, Summer L Gibbs, Jeong Heon Lee, Soon Hee Kim, Yoshitomo Ashitate, Fangbing Liu, Hoon Hyun, GwangLi Park, Yang Xie, Soochan Bae, Maged Henary and John V Frangioni doi:10.1038/nbt.2468 Diagnostic and surgical procedures that rely on optical imaging are improved by using near-infrared fluorescent probes with low background signal.
| | | | Single-base resolution methylomes of tomato fruit development reveal epigenome modifications associated with ripening pp154 - 159 Silin Zhong, Zhangjun Fei, Yun-Ru Chen, Yi Zheng, Mingyun Huang, Julia Vrebalov, Ryan McQuinn, Nigel Gapper, Bao Liu, Jenny Xiang, Ying Shao and James J Giovannoni doi:10.1038/nbt.2462 Whole-genome bisulfite sequencing reveals that global reprogramming of the epigenome occurs during the maturation of tomato fruits, potentially identifying new targets for breeders.
See also: News and Views by Ecker
| | | | Letters | | | | Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS production pp160 - 165 Mark P Brynildsen, Jonathan A Winkler, Catherine S Spina, I Cody MacDonald and James J Collins doi:10.1038/nbt.2458 The first global metabolic models that incorporate reactive oxygen species in E. coli reveal targets for potentiating the action of antibacterials.
See also: News and Views by Farha & Brown
| | | | High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire pp166 - 169 Brandon J DeKosky, Gregory C Ippolito, Ryan P Deschner, Jason J Lavinder, Yariv Wine, Brandon M Rawlings, Navin Varadarajan, Claudia Giesecke, Thomas Dorner, Sarah F Andrews, Patrick C Wilson, Scott P Hunicke-Smith, C Grant Willson, Andrew D Ellington and George Georgiou doi:10.1038/nbt.2492 A new method facilitates high-throughput sequencing of the repertoire of immunoglobulin heavy-light chain pairs in human B cells.
| | | | Metabolic engineering of Escherichia coli using synthetic small regulatory RNAs pp170 - 174 Dokyun Na, Seung Min Yoo, Hannah Chung, Hyegwon Park, Jin Hwan Park and Sang Yup Lee doi:10.1038/nbt.2461 Synthetic small RNAs are designed for use in metabolic pathway optimization in bacteria.
| | Careers and Recruitment | Top | | | | Fourth-quarter biotech job picture p175 Michael Francisco doi:10.1038/nbt.2505
| | | | People | | | | People p176 doi:10.1038/nbt.2511
| | Top | | | Advertisement | | | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | |
| | | |
No comments:
Post a Comment